| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | $11.2M-12.3% | $12.8M+42.2% | $9.0M+170.6% | $3.3M+5.0% | $3.2M |
| General and administrative | $238.5M-11.3% | $268.9M-5.9% | $285.8M+37.5% | $207.8M-51.4% | $427.5M |
| Depreciation and amortization | $28.6M+16.9% | $24.5M+52.5% | $16.0M+79.3% | $8.9M-14.6% | $10.5M |
| Impairments | $36.1M+903.5% | $3.6M | $0 | $0 | — |
| Total expenses | $6.40B+0.7% | $6.35B+39.7% | $4.55B+82.4% | $2.49B+31.7% | $1.89B |
| Income (loss) from operations | -$463.2M-58.6% | -$292.1M-25.8% | -$232.1M-120.3% | -$105.4M+71.7% | -$372.2M |
| Income (loss) from equity method investments | -$1.8M-112.2% | $15.0M-9.1% | $16.5M+53.8% | $10.7M+258.4% | -$6.8M |
| Other income (expense), net | $67.6M+96.1% | $34.5M+23.9% | $27.8M+99.9% | $13.9M+539.6% | $2.2M |
| Interest expense | -$6.6M-7.5% | -$6.2M+7.2% | -$6.7M-48.5% | -$4.5M+27.0% | -$6.1M |
| Income (loss) before income taxes | -$404.1M-62.4% | -$248.8M-28.0% | -$194.5M-114.5% | -$90.7M+76.3% | -$383.0M |
| Income tax benefit (expense) | -$1.3M+13.8% | -$1.5M-83.4% | -$791K-2942.3% | -$26K-101.5% | $1.7M |
| Income (loss) from continuing operations | -$405.3M-62.0% | -$250.3M-28.2% | -$195.3M-111.5% | -$92.3M+76.0% | -$383.9M |
| Income (loss) before gain (loss) on sales | $0+100.0% | -$1.1M+94.7% | -$20.0M | — | — |
| Gain (loss) and adjustments on sales of assets, net | $14.0M+259.8% | -$8.8M+81.6% | -$47.5M | $0 | — |
| Total discontinued operations | $14.0M+242.5% | -$9.8M+85.5% | -$67.5M-364.1% | -$14.6M+36.5% | -$22.9M |
| Net income (loss) | -$391.3M-50.5% | -$260.1M+1.0% | -$262.8M-145.9% | -$106.9M+73.7% | -$406.8M |
| Noncontrolling interests’ share in (earnings) loss | $0+100.0% | -$50K-124.2% | $207K-33.4% | $311K+3.7% | $300K |
| Net income (loss) attributable to common shares | -$391.3M-50.4% | -$260.2M+0.9% | -$262.6M-146.4% | -$106.6M+73.8% | -$406.5M |
| Continuing operations basic (in dollars per share) | -$980.00-60.7% | -$610.00-27.1% | -$480.00-118.2% | -$220.00+78.6% | -$1030.00 |
| Continuing operations diluted (in dollars per share) | -$980.00-60.7% | -$610.00-27.1% | -$480.00-118.2% | -$220.00+78.6% | -$1030.00 |
| Discontinued operations basic (in dollars per share) | $30.00+250.0% | -$20.00+87.5% | -$160.00-300.0% | -$40.00+33.3% | -$60.00 |
| Discontinued operations diluted (in dollars per share) | $30.00+250.0% | -$20.00+87.5% | -$160.00-300.0% | -$40.00+33.3% | -$60.00 |
| Weighted average shares outstanding, basic (in shares) | 414.0M+0.7% | 411.0M+0.5% | 408.9M+0.2% | 408.2M+9.4% | 372.9M |
| Weighted average shares outstanding, diluted (in shares) | 414.0M+0.7% | 411.0M+0.5% | 408.9M+0.2% | 408.2M+9.4% | 372.9M |
| Medical services revenue | |||||
| Expenses | $114.7M-46.2% | $213.2M-10.5% | $238.0M+30.1% | $183.0M+85.9% | $98.4M |
| Other operating revenue | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.